Back HIV Policy & Advocacy

HIV Policy & Advocacy

Supreme Court Allows Continuation of Affordable Care Act Subsidies in All States

On June 25 the U.S. Supreme Court issued a long-awaited decision in the King v. Burwell case, ruling that subsidies to help people purchase insurance coverage under the Affordable Care Act (ACA) -- popularly known as Obamacare -- are valid in all states, not just those that established their own insurance exchanges. The 6-3 decision will enable an estimated 6 million people to keep their subsidized health plans.

alt

Read more:

FDA Reduces Gay Blood Donation Ban to 1 Year After Sex, Critics Say It's Still Discriminatory

On May 12 the U.S. Food and Drug Administration (FDA) issued draft guidance stating that men who have sex with men should wait to donate blood until 12 months after their last sexual contact with another man. This is an improvement over the previous policy of lifetime deferral, but some advocates argue that the new regulations still discriminate against gay and bisexual men.

alt

Read more:

Obama Budget Boosts U.S. HIV and Hepatitis Funding, Cuts Global AIDS and TB

President Obama's proposed $4 trillion budget for fiscal year 2016 would increase funding for CDC's viral hepatitis and HIV prevention efforts, boost spending for HIV research, and allocate more to combat antibiotic resistance. The proposal would also change the law to allow Medicare to negotiate prescription drug prices, which could potentially save billions of dollars. But the plan would cut overall global health funding, including support for the Global Fund to Fight AIDS, Malaria, and Tuberculosis. 

alt

Read more:

BHIVA 2015: HIV Treatment Outcomes No Better with Single-tablet Regimens than Individual Pills

One-pill-a-day HIV treatments such as Atripla, Stribild, Complera, and Triumeq and Triumeq have the same rates of virological failure, drug resistance, and side effects as multiple tablet regimens, according to a meta-analysis presented to the British HIV Association (BHIVA) conference this week in Brighton. Single tablets cost the UK National Health Service (NHS) 5 five times more but have unproven clinical benefits, said Andrew Hill of Chelsea and Westminster Hospital.

alt

Read more:

San Francisco Stakeholders Flesh Out 'Getting to Zero' HIV Plan

Public health officials, healthcare providers, and community advocates provided more details and raised more questions about San Francisco's Getting to Zero plan for eliminating new HIV infections at a recent Board of Supervisors hearing. Attendees emphasized that funding for the new initiative should not come at the expense of existing HIV services.

alt

Read more: